Does ARRY hit $7 today, or do we need to wait a week or two
Excellence is not easy to find in this market, but ARRY is about as good as it gets. Valuation not yet to the stars, yet it has some major catalysts moving along well, a strong balance sheet, and its CEO is brilliant. I like the risk/reward outlook on this. In fact, I don't see much downside at all, it has numerous exciting trials occurring, all of which have the potential to seriously reward shareholders as well as patients. This could break $10 by year end, if its track record of success continues. No risk of a secondary either.
Well, you get the newbie award vanheus44. ARRY always pumps before the dump. Cantor Fitz can dilute you, as ARRY just basically offered more shares to sell. This always happens. Just ride the merry go round.